Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orr Barak

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
AN-2690, a novel antifungal for the topical treatment of onychomycosisOrr Barak, Daniel S Loo
Genomics|April 12, 2002
HBXAP, a novel PHD-finger protein, possesses transcription repression activityMeir Shamay, Orr Barak, Yosef Shaul
Journal of Cutaneous Pathology|April 24, 2010
PAS is optimal for diagnosing onychomycosisOrr Barak, Adam Asarch, Thomas Horn
Advances in Dermatology|December 15, 2005
Antimicrobial peptides: effectors of innate immunity in the skinOrr Barak, James R Treat, William D James
The Journal of Dermatological Treatment|July 16, 2008
Th17 cells: a new therapeutic target in inflammatory dermatosesAdam Asarch, Orr Barak, Daniel S Loo, et al.
The Journal of Dermatological Treatment|July 17, 2008
Th17 cells: a new paradigm for cutaneous inflammationAdam Asarch, Orr Barak, Daniel S Loo, et al.
The Journal of Biological Chemistry|January 15, 2002
Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcriptionMeir Shamay, Orr Barak, Gilad Doitsh, et al.
Obstetrical & Gynecological Survey|August 21, 2010
Paraneoplastic dermatoses associated with gynecologic and breast malignanciesDanielle Levine, Sheryl Miller, Najla Al-Dawsari, et al.
The Journal of Biological Chemistry|August 18, 2004
A tissue-specific, naturally occurring human SNF2L variant inactivates chromatin remodelingOrr Barak, Maribeth A Lazzaro, Neil S Cooch, et al.
Pediatric Dermatology|October 21, 2011
Paraneoplastic pemphigus and Castleman's disease in the setting of herpes simplex virus infectionLaine H Koch, Christle J Layton, Monika Pilichowska, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
AN-2690, a novel antifungal for the topical treatment of onychomycosisOrr Barak, Daniel S Loo
Genomics|April 12, 2002
HBXAP, a novel PHD-finger protein, possesses transcription repression activityMeir Shamay, Orr Barak, Yosef Shaul
Journal of Cutaneous Pathology|April 24, 2010
PAS is optimal for diagnosing onychomycosisOrr Barak, Adam Asarch, Thomas Horn
Advances in Dermatology|December 15, 2005
Antimicrobial peptides: effectors of innate immunity in the skinOrr Barak, James R Treat, William D James
The Journal of Dermatological Treatment|July 16, 2008
Th17 cells: a new therapeutic target in inflammatory dermatosesAdam Asarch, Orr Barak, Daniel S Loo, et al.
The Journal of Dermatological Treatment|July 17, 2008
Th17 cells: a new paradigm for cutaneous inflammationAdam Asarch, Orr Barak, Daniel S Loo, et al.
The Journal of Biological Chemistry|January 15, 2002
Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcriptionMeir Shamay, Orr Barak, Gilad Doitsh, et al.
Obstetrical & Gynecological Survey|August 21, 2010
Paraneoplastic dermatoses associated with gynecologic and breast malignanciesDanielle Levine, Sheryl Miller, Najla Al-Dawsari, et al.
The Journal of Biological Chemistry|August 18, 2004
A tissue-specific, naturally occurring human SNF2L variant inactivates chromatin remodelingOrr Barak, Maribeth A Lazzaro, Neil S Cooch, et al.
Pediatric Dermatology|October 21, 2011
Paraneoplastic pemphigus and Castleman's disease in the setting of herpes simplex virus infectionLaine H Koch, Christle J Layton, Monika Pilichowska, et al.
Pageof 2